C19orf48P and colorectal cancer: Several markers, oncogenes and suppressor genes, multidrug-resistance-related proteins, and genomic polymorphisms that influence DNA metabolism, DNA damage, programmed cell death, and angiogenesis may be responsible of colorectal cancer patient's variation in response to chemotherapy.